As president and CEO of the International Society for Pharmaceutical Engineering (ISPE), Nancy S. Berg leads the society’s efforts to stimulate industry-wide discussions on critical engineering, quality, manufacturing, supply chain and regulatory topics, and to help ISPE members and their companies resolve issues and understand, develop and implement next-generation manufacturing practices. She leads the 80-person staff in administering the programs, services and activities of the ISPE and supports the work of its organizational bodies. She also represents ISPE’s interests through interaction with a wide range of entities, including members, regulatory agencies; industry and academic leaders; and vendors, suppliers and manufacturers. She reports to the ISPE Board of Directors.
Berg has nearly 30 years of experience in technical association leadership, along with experience as an entrepreneur and business consultant to commercial and non-profit organizations.
She served as executive director/CEO of the Society of Manufacturing Engineers (SME) in Dearborn, Michigan from 2000 to 2006 when she left the society to launch her own consulting business focused on helping improve the effectiveness of businesses, start-ups and nonprofit organizations. While at the helm of SME, she directed the day-to-day operations of the $30-million/year, 200-employee organization and its worldwide businesses, including events and expositions, magazine publishing, technical communities, membership operations, and the SME Education Foundation.
At SME, Berg repositioned and streamlined operations, established a more customer-driven culture and integrated product and market development initiatives. She designed and launched the association’s strategic plan, Plan 2010. Berg and her management team were recognized by leading professional organizations, such as the American Society for Training and Development and the International Association of Business Communicators, for these efforts.
Prior to being selected as SME’s executive director and general manager, Berg was director of expositions, responsible for overseeing 21 domestic trade shows and pavilion events at foreign trade shows. Under her leadership, SME’s tradeshow activities grew exponentially and SME was named a top 10 trade show management company in the 1997 & 1998 Tradeshow Week Data Books. As a result of Berg’s strategic leadership, SME grew to have four of the nation’s top 200 trade shows recognized by Tradeshow Week. During this time, Berg spearheaded joint ventures, partnerships and strategic alliances with more than 100 associations, agencies, governments, institutions and organizations around the world.
Berg joined SME in 1982 as staff manager for Robotics International of SME (RI/SME), an association specializing in robotics technology. In 1984, she assumed responsibility for product development in the Expositions Division. Later, as Expositions Director, she also became responsible for strategic and financial planning, sales, communication and services, and show management. Earlier in her career, Berg worked in both the manufacturing and service industries.
Since 2007, Berg has consulted with organizations on strategic planning, leadership, sales and marketing, effective operations and business transformations. She has helped businesses become more effective, more influential, and more relevant by thinking strategically; planning long term; focusing their positioning and marketing around smart objectives, partnerships; and developing great leadership and committed employees.
In 2008, she also launched The Charleston Shutter Company, a custom exterior shutter company serving the architectural, commercial and residential construction industries. This company specializes in executive homes and 18th/19th century restorations and is now being run by members of her family and other representatives.
Throughout her career, Berg has been recognized as a ground-breaking leader. During her tenure with SME, she was the youngest person to head a global engineering/technical organization. She has been named one of Detroit’s “Top 100 Most Influential Women” by Crain’s Detroit Business and one of Michigan’s Top 50 Women by Corp! Magazine. She also received the Women of Achievement Award, Business & Industry by the YWCA of Western Wayne County Michigan.
Berg has been engaged in education and business issues at local, state and national levels. She has been recruited to serve on many government initiatives involving business, community, development, growth, revitalization and labor issues. She served on the Board of National Science Foundation-sponsored educational coalitions, as well as other boards and committees. She is a fundraiser for the Leukemia and Lymphoma Society’s Team in Training Program cycling events and the March of Dimes. She is a leader in her church and has served as professional advisor to executives and companies across many industries.
Berg is a graduate of the University of Michigan-Flint and is married to Timothy Jackson.
ISPE, the International Society for Pharmaceutical Engineering, is a Society of over 22,000 pharmaceutical professionals in 90 countries who use expert knowledge to create high-quality, cost-effective GMP solutions. ISPE is “Connecting a World of Pharmaceutical Knowledge” by providing Members with opportunities to develop their technical knowledge, exchange practical experience within their community, enhance their professional skills, and collaborate with global regulatory agencies and industry leaders. Founded in 1980, ISPE offers online learning opportunities for a global audience and has its worldwide headquarters in Tampa, Florida, USA; its European office in Brussels, Belgium; an Asia Pacific office in Singapore; and its newest office in Shanghai, China. Visit www.ISPE.org for additional Society news and information.
Biopharmaceutical Manufacturing Process Validation and Quality Risk Management
Monday, 05 Dec 2016 17.12
Know Before You Go: 2016 ISPE Biopharmaceutical Manufacturing Conference
Friday, 02 Dec 2016 17.12
Sights & Bites of San Francisco – 2016 ISPE Biopharmaceutical Manufacturing Conference
Thursday, 01 Dec 2016 13.12